Allogeneic bone marrow transplantation with T-cell-depleted marrow grafts for patients with poor-risk relapsed low-grade non-Hodgkin's lymphoma

British Journal of Haematology

Volumn 100, Issue 1, 1998, Pages 198-206

  Mandigers, C M P W ^a   Raemaekers, J M M ^a   Schattenberg, A V M B ^a   Roovers, E A ^a   Bogman, M J J T ^a   Van Der Maazen, R W M ^a   De Pauw, B E ^a   De Witte, T ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone marrow transplantation; Donor leucocyte infusions; Graft versus host disease; Low grade non Hodgkin's lymphoma; T cell depletion

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE DEPLETION; MALE; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECURRENCE RISK; T LYMPHOCYTE; WHOLE BODY RADIATION;

ADULT; BONE MARROW TRANSPLANTATION; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HUMANS; LEUKOCYTE TRANSFUSION; LYMPHOCYTE DEPLETION; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RECURRENCE; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0031972660     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00539.x     Document Type: Article

References (41)

1. Bär, B.M.A.M., Schattenberg, A., De Man, A.J.M., Hoogenhout, J., Boezeman, J. & De Witte, T. (1992) Influence of the conditioning regimen on erythrocyte chimerism, graft-versus-host disease and relapse after allogeneic transplantation with lymphocyte depleted marrow. Bone Marrow Transplantation, 10, 45-52.
2. Bastion, Y., Brice, P., Haioun, C., Sonet, A., Salles, G., Marolleau, J.P., Espinouse, D., Reyes, F., Gisselbrecht, C. & Coiffier, B. (1995) Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood, 86, 3257-3262.
3. Bensinger, W.I., Clift, R., Martin, P., Appelbaum, F.R., Demirer, T., Gooley, T., Lilleby, K., Rowley, S., Sanders, J., Storb, R. & Buckner, C.D. (1996) Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood, 88, 2794-2800.
4. Bierman, P.J., Vose, J.M., Anderson, J.R., Bishop, M.R., Kessinger, A. & Armitage, J.O. (1997) High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. Journal of Clinical Oncology, 15, 445-450.
5. Bross, D.S., Tutschka, P.J., Farmer, E.R., Beschorner, W.E., Braine, H.G., Mellits, E.D., Bias, W.B. & Santos, G.W. (1984) Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow. Blood, 63, 1265-1270.
6. Cheson, B.D. (1995) Infectious and immunosuppressive complications of purine analog therapy. Journal of Clinical Oncology, 13, 2431-2448.
7. Collins, R.H., Shpilberg, O., Drobyski, W.R., Porter, D.L., Giralt, S., Champlin, R., Goodman, S.A., Wolff, S.N., Hu, W., Verfaillie, C., List, A., Dalton, W., Ognoskie, N., Chetrit, A., Antin, J.H. & Nemunaitis, J. (1997) Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. Journal of Clinical Oncology, 15, 433-444.
8. Colombat, Ph., Donadio, D., Fouillard, L., Milpied, N., Tilly, H., Pico, J., Abgrall, J.F., Coiffer, B., Herbrecht, R. & Philip, T. (1994) Value of autologous bone marrow transplantation in follicular lymphoma: a France Autogreffe retrospective study of 42 patients. Bone Marrow Transplantation, 13, 157-162.
9. Davies, S.M., Wagner, J.E., Weisdorf, D.J., Shu, X.O., Blazar, B.R., Enright, H., McGlave, P.B. & Ramsay, N.K.C. (1996) Unrelated donor bone marrow transplantation for hematological malignancies: current status. Leukemia and Lymphoma, 23 221-226.
10. De Witte, T., Hoogenhout, J., De Pauw, B., Holdrinet, R., Janssen, J., Wessels, J., Van Daal, W., Hustinx, T. & Haanen, C. (1986) Depletion of donor lymphocytes by counterflow centrifugation successfully prevents graft-versus-host disease in matched allogeneic marrow triansplantation. Blood, 67, 1302-1308.
11. Dreger, P., Haferlach, T., Eckstein, V., Jacobs, S., Suttorp, M., Löffler, H., Müller-Ruchholtz, W. & Schmitz, N. (1994) G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. British Journal of Haematology, 87, 609-613.
12. Freedman, A.S., Gribben, J.G., Neuberg, D., Mauch, P., Soiffer, R.J., Anderson, K.C., Pandite, L., Robertson, M.J., Kroon, M., Ritz, J. & Nadler, L.M. (1996) High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood, 88, 2780-2786.
13. Freedman, A.S., Ritz, J., Neuberg, D., Anderson, K.C., Rabinowe, S.N., Mauch, P., Takvorian, T., Soiffer, R., Blake, K., Yeap, B., Coral, F. & Nadler, L.M. (1991) Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma. Blood, 77, 2524-2529.
14. Gale, R.P., Bortin, M.M., Van Bekkum, D.W., Biggs, J.C., Dicke, K.A., Gluckman, E., Good, R.A., Hoffmann, R.G., Kay, H.E.M., Kersey, J.H., Marmont, A., Masaoka, T., Rimm, A.A., Van Rood, J.J. & Zwaan, F.E. (1987) Risk factors for acute graft-versus-host disease. British Journal of Haematology, 67, 397-406.
15. Glucksberg, H., Storb, R., Fefer, A., Buckner, C.D., Neiman, P.E., Clift, R.A., Lerner, K.G. & Thomas, E.D. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation, 18, 295-304.
16. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K.C., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K.C., Grogan, T.M., Isaacson, P.G., Knowles, D.M., Mason, D.Y., Muller-Hermelink, H.K., Pileri, S.A., Piris, M.A., Ralfkiaer, E. & Warnke, R.A. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84 1361-1392.
17. Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, C., Speck, B., Truitt, R.L., Zwaan, F.E. & Bortin, M.M. (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood, 75, 555-562.
18. Johnson, P.W.M., Rohatiner, A.Z.S., Whelan, J.S., Price, C.G.A., Love, S., Lim, J., Matthews, J., Norton, A.J., Amess, J.A.L. & Lister, T.A. (1995) Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. Journal of Clinical Oncology, 13, 140-147.
19. Jones, R.J., Ambinder, R.F., Piantadosi, S. & Santos, G.W. (1991) Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood, 77, 649-653.
20. Kernan, N.A., Bartsch, G., Ash, R.C., Beatty, P.G., Champlin, R., Filipovich, A., Gajewski, J., Hansen, J.A., Henslee-Downey, J., McCullough, J., McGlave, P., Perkins, H.A., Phillips, G.L., Sanders, J., Stroncek, D., Thomas, E.D. & Blume, K.G. (1993) Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New England Journal of Medicine, 328, 593-602.
21. Khouri, I.F., Przepiorka, D., Van Besien, K., O'Brien, S., Palmer, J.L., Lerner, S., Mehra, R.C., Vriesendorp, H.M., Andersson, B.S., Giralt, S., Korbling, M., Keating, M.J. & Champlin, R.E. (1997) Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease. British Journal of Haematology, 97, 466-473.
22. Kolb, H.J., Schattenberg, A., Goldman, J.M., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., Niederwieser, D., Van Rhee, F., Mittermueller, J., De Witte, T., Holler, E. & Ansari, H. for the European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood, 86, 2041-2050.
23. Lokhorst, H.M., Schattenberg, A., Cornelissen, J.J., Thomas, L.L.M. & Verdonck, L.F. (1997) Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation. Blood, in press.
24. Longo, D.L., Young, R.C., Hubbard, S.M., Wesley, M., Fisher, R.I., Jaffe, E., Berard, C. & DeVita, V.T., Jr (1984) Prolonged initial remission in patients with nodular mixed lymphoma. Annals of Internal Medicine, 100, 651-656.
25. Marmont, A.M., Horowitz, M.M., Gale, R.P., Sobocinski, K., Ash, R.C., Van Bekkum, D.W., Champlin, R.E., Dicke, K.A., Goldman, J.M., Good, R.A., Herzig, R.H., Hong, R., Masaoka, T., Rimm, A.A., Ringden, O., Speck, B., Weiner, R.S. & Bortin, M.M. (1991) T-cell depletion of HLA-identical transplants in leukemia. Blood, 78, 2120-2130.
26. Meijerink, J.P.P., Goverde, G.J., Smetsers, T.F.C.M., Raemaekers, J.M.M., Bogman, M.J.J.T., De Witte, T. & Mensink, E.J.B.M. (1994) Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14:18) in a patient before and after allogeneic bone marrow transplantation. Annals of Oncology, 5, (Suppl. 1), S43-S45.
27. Molina, L., Nicolini, F., Viret, F., Pegourie-Bandelier, B., Leger, J. & Sotto, J.J. (1995) Allogeneic bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma. Blood, 86, (Suppl. 1), 209a.
28. Pavletic, Z.S., Bishop, M.R., Tarantolo, S.R., Martin-Algarra, S., Bierman, P.J., Vose, J.M., Reed, E.C., Gross, T.G., Kollath, J., Nasrati, K., Jackson, J.D., Armitage, J.O. & Kessinger, A. (1997) Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies. Journal of Clinical Oncology, 15, 1608-1616.
29. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y., Harousseau, J.L., Coiffier, B., Biron, P., Mandelli, F. & Chauvin, F. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. New England Journal of Medicine, 333, 1540-1545.
30. Raemaekers, J., De Witte, T., Schattenberg, A. & Van der Lely, N. (1989) Prevention of leukemic relapse after transplantation with lymphocyte depleted marrow by intensification of the conditioning regimen with a 6-day continuous infusion of anthracyclines. Bone Marrow Transplantation, 4, 167-171.
31. Rohatiner, A.Z.S., Johnson, P.W.M., Price, C.G.A., Arnott, S.J., Amess, J.A.L., Norton, A.J., Dorey, E., Adams, K., Whelan, J.S., Matthews, J., MacCallum, P.K., Oza, A.M. & Lister, T.A. (1994) Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. Journal of Clinical Oncology, 12, 177-1184.
32. Schattenberg, A., De Witte, T., Preijers, F., Raemaekers, J., Muus, P., Van der Lely, N., Boezeman, J., Wessels, J., Van Dijk, B., Hoogenhout, J. & Haanen, C. (1990) Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation. Blood, 75, 1356-1363.
33. Schonten, H.C., Colombat, Ph., Verdonck, L.F., Gorin, N.C., Björkstrand, B., Taghipour, G. & Goldstone, A.H., on behalf of the EBMT working party for lymphoma (1994) Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: the European Bone Marrow Transplant Group experience. Annals of Oncology, 5, (Suppl. 2), 147-149.
34. Schouten, H.C., Raemaekers, J.M.M., Kluin-Nelemans, H.C., Van Kamp, H., Mellink, W.A.M. & Van 't Veer, M.B., Dutch HOVON Group (1996) High-dose therapy followed by bone marrow transplantation for relapsed follicular non-Hodgkin's lymphoma. Annals of Hematology, 73, 273-277.
35. Shulman, H.M., Sullivan, K.M., Weiden, P.L., McDonald, G.B., Striker, G.E., Sale, G.E., Hackman, R., Tsoi, M.S., Storb, R. & Thomas, E.D. (1980) Chronic graft-versus-host syndrome in man. American Journal of Medicine, 69, 204-217.
36. Truitt, R.L. & Atasoylu, A.A. (1991) Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation. Blood, 77, 2515-2523.
37. Van Besien, K., Soboszinski, K., Rowlings, P., Philips, G., Vose, J., McCarthy, P., Klein, J. & Horowitz, M., for the International Bone Marrow Transplant Registry (1996) Allogeneic bone marrow transplantation for low grade lymphoma. Annals of Oncology, 7, (Suppl. 3), 71.
38. Van Besien, K.W., Khouri, I.F., Giralt, S.A., McCarthy, P., Mehra, R., Andersson, B.S., Przepiorka, D., Gajewski, J.L., Bellare, N., Nath, R., Romaguera, J.E., McLaughlin, P., Korbling, M., Deisseroth, A.B., Cabanillas, F.F. & Champlin, R.E. (1995) Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive treatment. Journal of Clinical Oncology, 13, 1096-1102.
39. Vandenberghe, P. & Boogaerts, M.A. (1995) Graft-versus-leukemia and graft-versus-lymphoma effects of allogeneic hone marrow transplantation and of allogeneic donor leukocyte transfusions. Annals of Hematology, 71, 209-217.
40. Weaver, C.H., Longin, K., Buchner, C.D. & Bensinger, W. (1994) Lymphocyte content in peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplantation, 13, 411-415.
41. Weisdorf, D.J., Andersen, J.W., Glick, J.H. & Oken, M.M. (1992) Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for marrow transplantation. Journal of Clinical Oncology, 10, 942-947.